149 related articles for article (PubMed ID: 11552906)
1. The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease.
Trudgill NJ; Hussain FN; Moustafa M; Ajjan R; D'Amato M; Riley SA
Aliment Pharmacol Ther; 2001 Sep; 15(9):1357-64. PubMed ID: 11552906
[TBL] [Abstract][Full Text] [Related]
2. Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans.
Ledeboer M; Masclee AA; Batstra MR; Jansen JB; Lamers CB
Gut; 1995 Jan; 36(1):39-44. PubMed ID: 7890233
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.
Boulant J; Mathieu S; D'Amato M; Abergel A; Dapoigny M; Bommelaer G
Gut; 1997 May; 40(5):575-81. PubMed ID: 9203932
[TBL] [Abstract][Full Text] [Related]
4. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans.
Zerbib F; Bruley Des Varannes S; Scarpignato C; Leray V; D'Amato M; Rozé C; Galmiche JP
Am J Physiol; 1998 Dec; 275(6):G1266-73. PubMed ID: 9843762
[TBL] [Abstract][Full Text] [Related]
5. Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects.
Hirsch DP; Mathus-Vliegen EM; Holloway RH; Fakhry N; D'Amato M; Boeckxstaens GE
Dig Dis Sci; 2002 Nov; 47(11):2531-7. PubMed ID: 12452391
[TBL] [Abstract][Full Text] [Related]
6. Effect of caloric density of a meal on lower oesophageal sphincter motility and gastro-oesophageal reflux in healthy subjects.
Pehl C; Pfeiffer A; Waizenhoefer A; Wendl B; Schepp W
Aliment Pharmacol Ther; 2001 Feb; 15(2):233-9. PubMed ID: 11148443
[TBL] [Abstract][Full Text] [Related]
7. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
Tonini M; De Giorgio R; De Ponti F
Drugs; 2004; 64(4):347-61. PubMed ID: 14969571
[TBL] [Abstract][Full Text] [Related]
8. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors.
Clavé P; González A; Moreno A; López R; Farré A; Cussó X; D'Amato M; Azpiroz F; Lluís F
Gastroenterology; 1998 Sep; 115(3):597-604. PubMed ID: 9721157
[TBL] [Abstract][Full Text] [Related]
9. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease.
van Herwaarden MA; Samsom M; Rydholm H; Smout AJ
Aliment Pharmacol Ther; 2002 Sep; 16(9):1655-62. PubMed ID: 12197845
[TBL] [Abstract][Full Text] [Related]
10. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R
Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392
[TBL] [Abstract][Full Text] [Related]
11. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.
Kahrilas PJ; Quigley EM; Castell DO; Spechler SJ
Aliment Pharmacol Ther; 2000 Nov; 14(11):1503-9. PubMed ID: 11069322
[TBL] [Abstract][Full Text] [Related]
12. Atropine inhibits gastric distension and pharyngeal receptor mediated lower oesophageal sphincter relaxation.
Mittal RK; Chiareli C; Liu J; Holloway RH; Dixon W
Gut; 1997 Sep; 41(3):285-90. PubMed ID: 9378379
[TBL] [Abstract][Full Text] [Related]
13. Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?
Hirsch DP; Tytgat GN; Boeckxstaens GE
Aliment Pharmacol Ther; 2002 Jan; 16(1):17-26. PubMed ID: 11856074
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
15. Effects of a specific CCK-A antagonist, Loxiglumide, on postprandial mood and sleepiness.
Wells AS; Read NW; Fried M; Borovicka J; D'Amato M
J Psychopharmacol; 1997; 11(3):241-6. PubMed ID: 9305416
[TBL] [Abstract][Full Text] [Related]
16. Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease.
Lidums I; Checklin H; Mittal RK; Holloway RH
Gut; 1998 Jul; 43(1):12-6. PubMed ID: 9771399
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
Corazziari E; Ricci R; Biliotti D; Bontempo I; De Medici A; Pallotta N; Torsoli A
Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
[TBL] [Abstract][Full Text] [Related]
18. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease.
Tam WC; Schoeman MN; Zhang Q; Dent J; Rigda R; Utley D; Holloway RH
Gut; 2003 Apr; 52(4):479-85. PubMed ID: 12631654
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the mechanism of gastro-oesophageal reflux and oesophageal acid exposure in patients with reflux disease.
Scheffer RC; Wassenaar EB; Herwaarden MA; Holloway RH; Samsom M; Smout AJ; Akkermans LM
Neurogastroenterol Motil; 2005 Oct; 17(5):654-62. PubMed ID: 16185303
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of gastro-oesophageal reflux in the lateral decubitus positions.
Kapur KC; Trudgill NJ; Riley SA
Neurogastroenterol Motil; 1998 Dec; 10(6):517-22. PubMed ID: 10050257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
